Literature DB >> 7835836

Observer variation in the assessment of chronic gastritis according to the Sydney system.

A Andrew1, J I Wyatt, M F Dixon.   

Abstract

The main aims of the Sydney system for the classification of gastritis are to improve uniformity in histopathological reporting and to provide a flexible matrix of rules for grading the histological features. We sought to determine the level of interobserver agreement between pathologists in the application of the Sydney system. Three histopathologists independently examined H & E, alcian blue/PAS and modified Giemsa stained sections of two antral and two corpus gastric biopsies from 69 consecutive dyspeptic patients. After elimination of five unsuitable cases, each observer graded chronic inflammation, polymorph activity, atrophy, intestinal metaplasia and Helicobacter pylori density in the antrum and corpus on a 0-3 scale according to the Sydney system criteria. The pairwise agreement on final diagnosis and the overall and conditional agreement on histological grades were examined by kappa statistics. Agreement on the final diagnosis ranged from 83-94% with kappa values of 0.699 ('good') to 0.887 ('excellent'). Conditional probability of agreement on a diagnosis of H. pylori positive gastritis was 99%, but wider disagreements were apparent in the recognition of H. pylori negative gastritis, reactive gastritis and even normal biopsies. Overall agreement for grade ranged from 70% for antral atrophy to 94% for intestinal metaplasia in the corpus with 'moderate' or 'good' kappa values. We conclude that the diagnostic and grading criteria described in the Sydney system can be applied consistently by histopathologists. The findings underline its potential usefulness in routine practice.

Entities:  

Mesh:

Year:  1994        PMID: 7835836     DOI: 10.1111/j.1365-2559.1994.tb01349.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  20 in total

1.  Rapid quantitative assessment of gastric corpus atrophy in tissue sections.

Authors:  N C van Grieken; M M Weiss; G A Meijer; E Bloemena; J Lindeman; G J Offerhaus; S G Meuwissen; J P Baak; E J Kuipers
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

Review 2.  Gastric precancerous lesions: heading for an international consensus.

Authors:  R M Genta; M Rugge
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

3.  Kappa statistics as indicators of quality assurance in histopathology and cytopathology.

Authors:  S S Cross
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

4.  [Source of variation in the diagnosis of Helicobacter pylori-associated multifocal atrophic gastritis.]

Authors:  Luis Eduardo Bravo; Juan Carlos Bravo; José Luis Realpe; Guillermo Zarama; MarÍa Blanca Piazuelo; Pelayo Correa
Journal:  Colomb Med (Cali)       Date:  2008-01

5.  Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis.

Authors:  X Y Chen; R W van der Hulst; M J Bruno; A van der Ende; S D Xiao; G N Tytgat; F J Ten Kate
Journal:  J Clin Pathol       Date:  1999-08       Impact factor: 3.411

6.  Patterns of gastritis in patients with gastro-oesophageal reflux disease.

Authors:  D J Bowrey; G W Clark; G T Williams
Journal:  Gut       Date:  1999-12       Impact factor: 23.059

Review 7.  Diagnosis of Helicobacter pylori by invasive test: histology.

Authors:  Ju Yup Lee; Nayoung Kim
Journal:  Ann Transl Med       Date:  2015-01

8.  Quantitative assessment of gastric atrophy using the syntactic structure analysis.

Authors:  A M Zaitoun; H al Mardini; C O Record
Journal:  J Clin Pathol       Date:  1998-12       Impact factor: 3.411

9.  Interobserver variation in histopathological assessment of Helicobacter pylori gastritis.

Authors:  Ozlem Aydin; Reyhan Egilmez; Tuba Karabacak; Arzu Kanik
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

10.  Helicobacter pylori in promotion of gastric carcinogenesis.

Authors:  M Rugge; M Cassaro; G Leandro; R Baffa; C Avellini; P Bufo; V Stracca; G Battaglia; A Fabiano; A Guerini; F Di Mario
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.